In vitro neuraminidase inhibitory concentrations (IC
50 % inhibitory concentration
Influenza virus
Neuraminidase inhibitor
Resistance
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
12 Oct 2023
12 Oct 2023
Historique:
received:
30
08
2023
revised:
27
09
2023
accepted:
10
10
2023
pubmed:
14
10
2023
medline:
14
10
2023
entrez:
13
10
2023
Statut:
aheadofprint
Résumé
To assess the extent of susceptibility to the four neuraminidase inhibitors (NAIs) approved in Japan of the epidemic viruses in the 2022-23 influenza season in Japan, we measured the 50 % inhibitory concentration (IC
Identifiants
pubmed: 37832825
pii: S1341-321X(23)00254-4
doi: 10.1016/j.jiac.2023.10.009
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest H. Ikematsu has previously received honoraria from Daiichi Sankyo Co., Ltd. for medical advice and lectures. Additionally, we have been supplied with laninamivir by Daiichi Sankyo Co., Ltd. for the purpose of conducting IC(50) assays.